Nektium Pharma
Nektium Pharma is a privately held Spanish botanical ingredient developer and manufacturer that discovers, standardizes, and commercializes clinically-validated branded plant extracts — including Zynamite®, Rhodiolife®, Vanizem®, and Xanthigen® — for nutraceutical, sports nutrition, and functional food and beverage manufacturers worldwide, sold through a global network of exclusive distribution partners.
- Company typePrivate
- Founded1997
- HeadquartersMorristown, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nektium Pharma does
Nektium Pharma S.L. is a privately held Spanish botanical ingredient developer and manufacturer founded in 1997 and headquartered in Agüimes, Las Palmas (Canary Islands), with additional commercial presence in Morristown, USA. The company discovers, standardizes, and commercializes science-based plant extracts sold as branded ingredients to nutraceutical, sports nutrition, and functional food and beverage manufacturers worldwide. Its portfolio is anchored on Zynamite® (Mangifera indica mango leaf extract standardized to ≥60% mangiferin, sold in standard, water-soluble S, and PX-with-quercetin variants), Rhodiolife® (Rhodiola rosea adaptogen), Vanizem® (Aframomum melegueta / Grains of Paradise for mood and sleep, via endocannabinoid mechanism), Xanthigen® (pomegranate extract), and supporting ingredients including organic elderberry extract and Echinacea angustifolia. Operations are supported by a 10,000m² GMP-certified manufacturing and R&D complex, a 100kW on-site photovoltaic installation covering over 30% of electricity use, and a dense regulatory stack including FSSC 22000, ISO 14001, EU GMP, NIS2, organic operator status, B Corp, GRAS (Zynamite®), BSCG drug-free (Rhodiolife®), CITES, and Nagoya Protocol BioTrade permits.
Nektium's core technology rests on two pillars: (1) 25+ years of proprietary extraction, standardization, and clinical research across its branded ingredients, with 10+ peer-reviewed studies on Zynamite® alone conducted with partners including Northumbria University and the University of Las Palmas de Gran Canaria; and (2) Smartek by Nektium™, a proprietary delivery technology platform combining multi-stage microencapsulation, molecular and matrix inclusion systems, and controlled ionization to stabilize and optimize bioactive compounds. The company holds US Patent 10,537,604 and international patent coverage for Zynamite® covering brain activity, alertness, concentration, memory, mood, stress reduction, and caffeine replacement applications, providing a defensible IP position around its flagship ingredient.
The business model is B2B ingredient supply with three revenue streams: (a) branded ingredient sales via direct contracts and a global network of exclusive regional distribution partners — PLT Health Solutions for North America, Phytonet for Turkey/Balkans/SE Asia, Deimos for Italy/San Marino, Becarre Natural for France/Belgium/Luxembourg, Ryusendo for Japan, Brenntag for South Africa, Pathway International for Australia/NZ, and Jupiter International for Korea; (b) licensing and royalty arrangements on branded ingredients; and (c) co-development and clinical research collaborations with academic institutions. Pricing is volume- and specification-dependent under multi-year contracts, with no public list pricing. The company is founder-controlled under CEO Miguel Jiménez del Rio and Director of Science Dr. Nigel Gericke, with no disclosed institutional venture capital or private equity; the only external capital raised to date is a €2,679,131 European Regional Development Fund grant awarded in 2015 to fund the Gran Canaria facility build.
Nektium Pharma firmographics
Firmographics- Name
- Nektium Pharma
- Legal name
- Nektium Pharma S.L.
- Website
- https://nektium.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nektium Pharma is a privately held Spanish botanical ingredient developer and manufacturer that discovers, standardizes, and commercializes clinically-validated branded plant extracts — including Zynamite®, Rhodiolife®, Vanizem®, and Xanthigen® — for nutraceutical, sports nutrition, and functional food and beverage manufacturers worldwide, sold through a global network of exclusive distribution partners.
- Ownership category
- akta.pro rank
Nektium Pharma industry classification
Industry- Product category
- Botanical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
- akta.pro secondary industries
- Herbal & Botanical Supplements (CRADAGAD), Natural Extracts & Botanical Concentrates for Beverages (herbal, spice, aromatic extracts) (AFAFAGAJ), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where Nektium Pharma is headquartered
LocationHeadquarters
- HQ city
- Morristown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Nektium Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Branded Botanical Ingredient Sales: Nektium manufactures and sells proprietary branded botanical extracts including Zynamite®, Rhodiolife®, Vanizem®, Xanthigen®, and elderberry extracts to nutraceutical, sports nutrition, and food & beverage companies. Revenue is generated through direct ingredient supply contracts and distribution partner channels globally.
- Licensing of Branded Ingredients: Zynamite® and other branded ingredients are commercialized through licensing partnerships such as the agreement with PLT Health Solutions for North American distribution, generating licensing and royalty revenue.
- Co-development and Clinical Research Services: Nektium collaborates with distribution partners and academic institutions (e.g., University of Las Palmas de Gran Canaria, Northumbria University) to co-develop proprietary ingredient combinations and formulations, creating differentiated market positions and licensing opportunities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient pricing — volume and specification-dependent |
Go-to-market motion3 records
Distribution channels8 records
Marketing channels5 records
Nektium Pharma product offering
Product offeringCore offering
Nektium Pharma discovers, develops, manufactures, and commercializes science-based proprietary branded botanical extracts—including Zynamite®, Rhodiolife®, Vanizem®, Xanthigen®, Echinacea angustifolia, elderberry extracts, and honeybush—for sale to nutraceutical, sports nutrition, and functional food & beverage manufacturers. The company operates a GMP-certified production facility in Gran Canaria, Spain, and leverages the proprietary Smartek by Nektium™ delivery technology platform (combining microencapsulation, molecular inclusion, and controlled ionization) to enhance the stability, bioavailability, and formulation versatility of its bioactive extracts.
Product overview
Nektium Pharma is a botanical ingredient developer and manufacturer offering a portfolio of branded, clinically-researched plant extracts for the nutraceutical, functional food, and beverage industries. The company's product portfolio centers on four main branded ingredients: Zynamite® (caffeine-free mango leaf nootropic for mental/physical energy, available in standard, water-soluble S, and PX with quercetin variants), Rhodiolife® (adaptogen from Rhodiola rosea for stress and cognition), Vanizem® (fast-acting mood and sleep ingredient from Aframomum melegueta), and Xanthigen® (botanical extract). Supporting products include organic elderberry extract and Echinacea angustifolia for immune health. The company also offers the Smartek by Nektium™ proprietary delivery technology platform that enhances botanical efficacy through microencapsulation and controlled ionization. Nektium operates GMP-certified manufacturing facilities in Gran Canaria, Spain, and holds multiple certifications including B Corp, FSSC 22000, ISO 14001, and NIS2 compliance.
Differentiator
Problem solved
Functional benefit
Brands
- Rhodiolife®: Proprietary standardized Rhodiola rosea extract, an adaptogen for cognitive health and sports performance, standardized to total rosavins and salidroside
- Vanizem®
- Xanthigen®
- Zynamite®
- Smartek by Nektium™
- Zynamite® PX
- Zynamite® S
Products and services
- Zynamite® Caffeine-free proprietary extract of Mangifera indica (mango) leaves standardized to ≥60% mangiferin. A clinically-studied nootropic and ergogenic ingredient providing mental and physical energy without caffeine side effects, supported by 10+ clinical studies. Sold as a B2B ingredient to nutraceutical, sports nutrition, and functional food & beverage manufacturers.
- Zynamite® S Water-soluble formulation of Zynamite® mango leaf extract for functional beverages. Features neutral taste, heat stability, and improved absorption of mangiferin, designed for RTDs, shots, and other beverage applications where solubility is key.
- Zynamite® PX Patented combination of Zynamite® mango leaf extract with quercetin. Synergistic sports nutrition ingredient demonstrating enhanced peak power output, faster recovery, reduced muscle pain, and exercise-mimetic properties in skeletal muscle.
- Rhodiolife® Standardized Rhodiola rosea extract from the Altai mountains, standardized for total rosavins and salidroside. Adaptogen supporting stress relief, cognitive function, and sports performance, available in standard and BSCG-certified drug-free sports grades.
- Vanizem® Fast-acting botanical extract from Aframomum melegueta (Grains of Paradise). Clinically proven to improve mood, reduce stress, and enhance sleep quality within 3 days, targeting the endocannabinoid system without sedative effects.
- Xanthigen® Patented pomegranate extract ingredient featured in Nektium's portfolio alongside Rhodiolife® and Zynamite® as a principal product.
- Organic elderberry extract Organic Black Elderberry (Sambucus nigra) extract available in 6% and 10% anthocyanin concentrations. Natural immune health ingredient with antioxidant properties.
- Echinacea angustifolia Immune booster ingredient standardized to 4% echinacoside, produced from Echinacea angustifolia roots with historical use and scientific evidence for immune support and resistance to bacterial and viral diseases.
- Honeybush (Cyclopia spp.) Naturally sweet, caffeine-free botanical from South Africa's Cape Floral Kingdom. Rich in antioxidants and mangiferin, with anti-diabetic, anti-obesity, and immunomodulatory properties; under development with Nagoya BioTrade permit secured for sustainable and ethical South African sourcing.
- Smartek by Nektium™ Proprietary delivery technology platform incorporating multi-stage microencapsulation, molecular inclusion systems, and controlled ionization. Shields and stabilizes bioactive compounds in botanicals for enhanced efficacy, stability, and versatility in formulations including gummies and beverages.
Quantifiable outcome
- Improved cognitive performance including processing speed, focus, attention, and mental flexibility within 30 minutes of a single 100–150mg dose of Zynamite® S, lasting up to 5 hours
- +8 more outcomes
Companies that use Nektium Pharma
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Nektium Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Nektium Pharma partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Parceval (Pty) LtdcoreSouth African distributor that helped Nektium secure its first Nagoya Protocol BioTrade permit for honeybush sourcing. Parceval has already secured multiple BioTrade and Bioprospecting permits for natural resources from South Africa and guided Nektium through the permit application process, including consultation with the San Council of South Africa and National Khoisan Council.
- Agulhas Honeybush TeaminorLocal South African raw material supplier that secured a permit demonstrating compliance with the Nagoya Protocol in December 2023. Nektium partners with Agulhas to ensure sustainable cultivation of honeybush that preserves wild stocks, encourages agricultural biodiversity, and promotes carbon sequestration.
- DeimoscoreFood ingredient and nutraceutical distribution specialist appointed in June 2023 to distribute Nektium's botanical portfolio in Italy and San Marino — the largest European market for nutraceuticals in terms of spending per capita.
- Becarre NaturalcoreFrench plant extract specialist Becarre Natural was formalized as exclusive distributor of Nektium's products throughout France, Belgium, and Luxemburg in June 2023. The partnership built on an existing 10-year relationship, expanding coverage to all three Benelux countries.
- RyusendocoreJapanese supplement specialist Ryusendo signed a distribution agreement in June 2023 for Rhodiolife®, launched at ifia/HFE Japan in May 2023. The strategic partnership includes provisions for Ryusendo to conduct proprietary work and potentially its own scientific research into Rhodiolife® benefits in the Japanese market.
- CITES (Convention on International Trade in Endangered Species of Flora and Fauna)coreFollowing CITES' addition of Rhodiola spp. to Appendix II in November 2022 and the EU's addition to Annex B in May 2023, Nektium secured CITES-compliant trade permits for its Rhodiolife® inventory from Spanish authorities, ensuring continued global commercialization of the ingredient.
- Northumbria University — Brain, Performance and Nutrition Research CentrecoreAcademic research partnership led by Professor David Kennedy for clinical studies on Zynamite®'s cognitive effects. The double-blind, placebo-controlled study published in Nutrients (2020) tested a single 300mg dose of Zynamite® on cognitive functions in 70 healthy adults, demonstrating significant improvements in attention and memory.
- PLT Health SolutionscorePLT Health Solutions is the exclusive North American marketing and distribution partner for the Zynamite® family of ingredients (Zynamite®, Zynamite® S, Zynamite® PX). The partnership was formalized following Zynamite®'s GRAS self-affirmation in October 2019, enabling PLT to market the ingredient as a food ingredient for mental and physical energy in the US market. PLT manages commercial strategy, customer development, and research communication for the US market.
- Brenntag South AfricaminorDistribution partner covering several African countries for Nektium's botanical extract portfolio, announced as part of Nektium's expanding network of distribution partners in November 2018.
- Pathway InternationalminorDistribution partner for Australia and New Zealand for Nektium's botanical extract portfolio, announced as part of Nektium's global distribution network expansion in November 2018.
- Jupiter InternationalminorDistribution partner for Korea for Nektium's botanical extract portfolio, announced as part of the company's expanding global distribution network in November 2018.
- PhytonetcoreStrategic commercial partnership established in 2018 with Swiss-based Phytonet for distribution of Nektium's botanical extract portfolio including Rhodiolife®, P40p™, and Zynamite® in Turkey, several Balkan countries, and South East Asia. The partnership aligned with Nektium's strategy to expand sales to wider geographical areas internationally using Phytonet's established network in these markets.
- University of Las Palmas de Gran Canaria (ULPGC)coreResearch collaboration with ULPGC's Human Performance Lab led by Professor José A. L. Calbet investigating sports performance activities of Zynamite®, with findings published in Frontiers in Physiology. The collaboration contributed to Zynamite®'s Nutraingredients Award and continues through ongoing clinical studies.
Scale indicators8 records
Recent moves9 records
Expansion highlights7 records
Nektium Pharma competitors and assessment
Company assessmentDirect peers
- Indena: Indena is an Italian botanical extract manufacturer producing pharmaceutical-grade and nutraceutical-grade plant extracts with deep standardization expertise — closely matching Nektium's vertically integrated, GMP-certified, standardized botanical-extract manufacturing in the Canary Islands.
- PLT Health Solutions: PLT Health Solutions is Nektium's exclusive North American distribution partner for the Zynamite® family and itself develops and distributes branded botanical ingredients (e.g., Spektrum, Zembrin) to the same nutraceutical and functional food customer base — a tightly comparable branded-ingredient peer.
- Euromed S.A. Euromed is a Spanish-headquartered botanical extract producer serving the nutraceutical and phytopharmaceutical markets with standardized fruit, vegetable and herbal extracts, a near-twin to Nektium's regulated botanical-ingredient platform in Southern Europe.
- OmniActive Health Technologies: OmniActive develops proprietary branded nutraceutical ingredients (e.g., Lutemax, CurcuWIN) with peer-reviewed clinical evidence sold B2B to supplement and functional food formulators, overlapping directly with Nektium's evidence-led, patented-ingredient model for cognitive, eye and metabolic health.
- Sabinsa: Sabinsa is a leading manufacturer of standardized botanical extracts and branded nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine), serving identical nutraceutical, sports nutrition and functional food customers with proprietary, clinically-backed ingredient SKUs — directly comparable to Nektium's Zynamite® and Rhodiolife® franchise.
- Gencor: Gencor is a branded botanical ingredient maker serving the global nutraceutical and dietary supplement industry, with proprietary extracts supported by clinical studies and a B2B distribution model closely mirroring Nektium's go-to-market across cognitive, sports and stress-related categories.
Emerging players
- Applied Food Sciences: Applied Food Sciences produces proprietary, certified-organic botanical extracts (e.g., CoffeeBerry, Vivapure) for beverage and functional food manufacturers, sharing Nektium's clinical-evidence and sustainability-certification emphasis though at a more beverage-focused footprint.
- DolCas Biotech: DolCas Biotech is a smaller branded botanical ingredient developer bringing clinically researched plant extracts (e.g., Curcumin, Boswellia) to supplement formulators, with a similar focus on patent/IP-protected, science-backed SKUs that competes at the smaller end of Nektium's category.
Broad incumbents
- Naturex (Givaudan): Naturex, now part of Givaudan's Active Beauty and Taste & Wellbeing divisions, is a broad natural-ingredients platform producing botanical extracts, fruit & vegetable powders and nutraceutical actives — a much larger incumbent with overlapping capability in standardized botanical extracts for supplements and beverages.
- Kemin Industries: Kemin is a diversified ingredient manufacturer producing botanical and functional ingredients across human nutrition, animal health and personal care, operating at much larger scale across multiple categories and overlapping with Nektium's standardized botanical extracts in nutraceutical and functional food applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Nektium Pharma social profiles
Digital presenceNektium Pharma compliance and trust
Trust signalCompliance10 records
Nektium Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nektium Pharma leadership team
Management profileNumber of profiles
Profiles11 records
Nektium Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nektium Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nektium Pharma
What does Nektium Pharma do?
Nektium Pharma discovers, develops, manufactures, and commercializes science-based proprietary branded botanical extracts—including Zynamite®, Rhodiolife®, Vanizem®, Xanthigen®, Echinacea angustifolia, elderberry extracts, and honeybush—for sale to nutraceutical, sports nutrition, and functional food & beverage manufacturers. The company operates a GMP-certified production facility in Gran Canaria, Spain, and leverages the proprietary Smartek by Nektium™ delivery technology platform (combining microencapsulation, molecular inclusion, and controlled ionization) to enhance the stability, bioavailability, and formulation versatility of its bioactive extracts.
Is Nektium Pharma a public or private company?
Nektium Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nektium Pharma founded?
Nektium Pharma was founded in 1997. It employs 11 to 50 people.
Where is Nektium Pharma based?
Nektium Pharma is headquartered in Morristown, United States, in the North America region.
How does Nektium Pharma make money?
Three revenue lines are on record. Branded Botanical Ingredient Sales are the primary driver. The others are licensing of Branded Ingredients and co-development and Clinical Research Services.
Who are Nektium Pharma's main competitors?
Direct peers on record are Indena, PLT Health Solutions, Euromed S.A., OmniActive Health Technologies, Sabinsa and Gencor. Emerging players are Applied Food Sciences and DolCas Biotech. Broad incumbents are Naturex (Givaudan) and Kemin Industries.
Does Nektium Pharma have an API?
No public API is recorded for Nektium Pharma.
What industry is Nektium Pharma in?
Nektium Pharma's product category is Botanical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.